The Seventy-first World Health Assembly: Interview with Dr. James Fitzgerald, Director of Health Systems and Services PAHO/WHO about Universal health coverage: what it means and how we can achieve it: http://www.who.int/world-health-assembly/seventy-first/social-good
The World Health Assembly The World Health Assembly (WHA) is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board.
The main functions of the World Health Assembly are to determine the policies of the Organization, supervise financial policies, and review and approve the proposed programme budget.
This year’s Health Assembly takes place on 21–26 May 2018 in Geneva, Switzerland.
The Federal Commissioner for Protection against Sanitary Risks, Julio Sánchez and Tépoz, reported that so far in this federal administration, COFEPRIS has secured 10.1 million irregular medical devices and seized more than 335 tons of irregular drugs.
The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks.
The National Administration of Medicines, Food and Medical Technology calls for a scholarship for the granting of a scholarship under the “Research Scholarship in Regulatory Science” approved by Disposition ANMAT 10451/17, on “Obtaining and preclinical evaluation of pharmaceutical nanovehicles for application in the treatment of Chagas disease “.
MedWatch – The FDA Safety Information and Adverse Event Reporting Program
A new MedWatch Safety Alert: Keytruda (pembrolizumab) or Tecentriq (atezolizumab): FDA Alerts Health Care Professionals and Investigators: FDA Statement – Decreased Survival in Some Patients in Clinical Trials Associated with Monotherapy intended for: Oncology, Pharmacy, Risk Manager was just added to the FDA MedWatch Webpage.
You can read the complete MedWatch Safety Alert that includes recommendations at: https://go.usa.gov/xQPtf
Source: World health statistics 2018: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2018. CC BY-NC-SA 3.0 IGO.
ISBN: 978-92-4-156558-5
Published online: May 2018
The World Health Statistics series is WHO’s annual snapshot of the state of the world’s health. This 2018 edition contains the latest available data for 36 health-related Sustainable Development Goal (SDG) indicators. It also links to the three SDG-aligned strategic priorities of the WHO’s 13th General Programme of Work: achieving universal health coverage, addressing health emergencies and promoting healthier populations.
The latest data show that:
:: Less than half the people in the world today get all of the essential health services they need.
:: In 2010, almost 100 million people were pushed into extreme poverty because they had to pay for health services out of their own pockets.
:: 13 million people die every year before the age of 70 from cardiovascular disease, chronic respiratory disease, diabetes and cancer – most in low and middle-income countries.
:: Every day in 2016, 15 000 children died before reaching their fifth birthday.
:: 303 000 women died due to complications of pregnancy or childbirth in 2015. Almost all of these deaths occurred in low- and middle-income countries (99%). Reducing maternal mortality crucially depends upon ensuring that women have access to quality care before, during and after childbirth.
For details and additional information / Más información y material adicionalclick here.
The Brazilian Health Surveillance Agency (Anvisa) certified for the first time in Good Manufacturing Practices (GMP) two Colombian pharmaceutical laboratories without a visit, which is based exclusively on inspection reports of the National Institute of Food and Drug Surveillance (Invima).
The certified laboratories are: Procaps S.A (Barranquilla) and Eurofarma Colombia S.A.S. (Bogotá).
This important achievement is based through the level of recognition that Invima gained by being a National Regulatory Authority of Regional of Reference (NRAr) level VI by the Pan American Health Organization (PAHO), indicating that the agency has uniform and transparent methodologies for the fulfillment of its functions of control, efficacy, safety and quality of medicines. Likewise, ANVISA is also recognized as one of the eight NRAr.
